1st Edition

Sleep Disorders Diagnosis and Therapeutics

    One of the first such volumes in this field, Sleep Disorders: Diagnosis and Therapeutics explores sleep pharmacology and therapeutics. Leading researchers in the area of experimental and clinical and psychopharmacology critically assess the progress in their specialist fields. The book is suitable as an introduction for clinicians and researchers who are new to sleep pharmacology and outlines the wider range of therapeutic options currently available to them. For seasoned clinicians, the book will assist in selecting the most appropriate methodologies and treatment options designed to circumvent the problems in combating sleep disorders.

    1. Classification of Sleep Disorders  2. Sleep Loss and Sleepiness  3. Approach to the patient with sleep complaint  4. Manifestations of hypersomnia  5. Neuropsychology of Sleep  6. Receptor mechanisms in sleep and wakefulness  7. Transient Insomnia: A Behavioral Sleep Medicine Perspective  8. Chronic insomnia  9. Robound with Hypnotic medication  10. Benzodiazepines: An overview  11. Benzodiazepines: Effects on memory functioning  12. Behavioral therapy, sleep hygiene and psychotherapy  13. Sleep factors  14. The Cytoch P450 enzyme systems: Its relevance to the Pharmacology of sleep  15. Pharmacokinetics: Basic Concepts for dosage regimen considerations  16. Chronopharmacology: Principles and applications in sleep medicine  17. Sleep and Geriatric Psychopharmacology  18. Antihistamines and sleep  19. First generation hypnotics and sedatives  20. GABA-BZD receptors as target for new hypnotics  21. Benzodiazepines: Effects on sleep  22. Indiplon  23. Serotonergic drugs as sleep medications  24. Prostaglandins and sleep/wake regulation  25. Function of endocannabinoids and related compounds in sleep  26. Sleep Medications: When to Prescribe and Rationale for Use  27. Stimulants: Mechanisms and Therapeutic Prospects  28. Zolpidem: its use in the treatment of sleep disorders  29. Eszopiclone: Efficacy and Safety  30. Zaleplon  31. Z-Drugs: Comparative tolerability  32. Rationale for the development of the Zā€“drugs  33. Metalonin and other indolamines: their involvement in sleep regulation  34. Ramelteon: a Melatonin receptor agonist  35. The rationale for the development of melatonin receptor ligands  36. Schizophrenia, Sleep and Antipsychotic Drugs  37. Interrelationships Between Sleep, Depression and Antidepressant Drugs  38. Effect of antiepileptic medications on sleep architecutre  39. Hormones and sleep  40. Timezone travel, jet lag and sleep disturbances  41. Alcohol, Sleep, Sleep Disorders, and Consequent Daytime Impairment   42. Sleep medication and traffic safety  43. Effect of hypnotic drugs on body balance and standing steadiness  44. Neuropharmacology of Opioids  45. Sleep and Breathing Disorders in Adults  46. Continuous Positive Airway Pressure Therapy  47. Pharmacological Treatment of Obstructive Sleep Apnea  48. Surgical Options in Snoring and Obstructive Sleep Apnea  49. Restless Legs Syndrome: Treatment Options  50. Restless Legs Syndrome: effects on cognitive functioning, memory and psychomotor performance  51. Pharmacological treatment of narcolepsy  52. Modafinil and neuropharmacology of Narcolepsy  53. Narcolepsy: effects on cognitive functioning, memory and psychomotor performance  54. Dreams: Physiology, Pharmacology and Psychology  55. Sleep and Dreaming: Medication effects and side-effects  56. The Subjective Measurement of Excessive Daytime Sleepiness  57. The Multiple Sleep Latency Test and Maintenance of Wakefulness Test: Use and Procedures  58. The OSLER test  59. The Pittsburgh Sleep Quality Index  60. Scoring Rules and General Guidelines for the Pittsburgh Insomnia Rating Scale (PIRS)  61. The Athens Insomnia Scale  62. The Leeds Sleep Evaluation Questionnaire (LSEQ) for psychopharmacology research  63. Sleep Hygiene Practice Scale (SHPS)  64. Cyclic Alternating pattern (CAP)  65. Body Mass Index


    S.R. Pandi-Perumal is a Sleep Disorders Specialist at the State University of New York / Downstate Medical Center (SUNY DMC) which is a major provider of medical education, healthcare, and research in the downstate New York region. He is well-recognized sleep researcher both nationally and internationally, and has authored many publications in the field of sleep, dreams, and biological rhythms. He currently holds many professional memberships, including Sleep Research Society, USA and the American Academy of Sleep Medicine, USA. His area of research interest includes sleep and biological rhythms. He has edited many books related to sleep and biological rhythms research and also an editorial member (regular) of Journal of Circadian Rhythms. He was featured in New York Times last year. Joris C Verster is a researcher in Human Psychopharmacology at the Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, the Netherlands. Verster was born in Breda, the Netherlands in 1970. He graduated in 1997 with a major in Biopsychology. In 2002, Verster became a doctor in psychology. Verster has conducted several outstanding studies in human pschopharmacology, including the residual effects of Zaleplon and Zolpidem on driving ability, cognition, memory functioning and psychomotor performance, the day following middle-of-the-night administration. Jaime M. Monti is a Professor of Pharmacology and Therapeutics at the School of Medicine, University of the Republic, Montevideo, Uruguay. He is the director of the Sleep Research Laboratory at the Department of Pharmacology and Therapeutics at the School of Medicine. Prof. Monti received his medical degree from the University of the Republic, and completed a post-doctoral psychopharmacology research training fellowship at the University of Stanford, California, USA. Since 1970, Prof. Monti has published over one hundred and fifty peer reviewed articles and book chapters and twenty invite